Third, HER-2 heterogeneity in GC has been confirmed within the same tumor, and even within the same tumor gland; thus, HER-2 expression should be tested with at least 3–4 slides in tumors other than HER2 3 + [35, 36]. The gene discussed is ERBB2; the disease is neoplasm.